Streetbeat News

Analyst Ratings

CUBE

In the last 3 months, 5 analysts have provided 12-month price targets for CubeSmart (NYSE:CUBE), with an average target of $52.0, up 2.62% from the previous average of $50.67.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 9:02 pm

KSS

Kohl's (NYSE:KSS) has received mixed analyst ratings in the last quarter, with an average 12-month price target of $23.42, down 8.52% from the previous average of $25.60. Analysts' opinions on the stock range from bullish to bearish.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 9:01 pm

CUE

Analysts have provided bullish and somewhat bullish ratings for Cue Biopharma (NASDAQ:CUE) in the last quarter, with an average 12-month price target of $10.25, up 13.89% from the previous average of $9.00.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 9:01 pm

OMF

OneMain Holdings (NYSE:OMF) has received 1 bullish, 5 somewhat bullish, and 1 indifferent rating from analysts in the last quarter. The average price target is $50.0, up 1.52% from the previous target of $49.25, implying an upside compared to the current price of $43.76.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 9:00 pm

PYPL

PayPal Holdings, Inc. (NASDAQ:PYPL) shares are trading higher after several analysts provided updated price targets this week. BTIG analyst Lance Jessurun initiated coverage with a Buy rating and a price target of $85, while Atlantic Equities analyst Kunaal Malde downgraded the stock to Neutral with a $72 price target.

Portfolio Pulse from Ryan Gustafson

June 15, 2023 | 8:03 pm

BERY

Five analysts have provided ratings for Berry Global Gr (NYSE:BERY) within the last quarter, with an average price target of $71.4, implying an upside from the current price of $63.29. The current average has increased by 5.51% from the previous average price target of $67.67.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 8:02 pm

CHKP

In the last quarter, Check Point Software (NASDAQ:CHKP) received 3 somewhat bullish, 8 indifferent, and 1 somewhat bearish analyst ratings. The average 12-month price target for CHKP is $130.83, a 4.43% decrease from the previous average of $136.89.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 8:01 pm

CGEM

Analysts have provided bullish ratings for Cullinan Oncology (NASDAQ:CGEM) in the last quarter, with an average 12-month price target of $49.25, a 1.5% decrease from the previous average price target of $50.00.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 8:01 pm

IOVA

In the last quarter, Iovance Biotherapeutics (NASDAQ:IOVA) received 7 bullish, 4 somewhat bullish, and 2 indifferent analyst ratings. The average price target is $24.31, a significant increase from the previous target of $19.60, implying upside potential.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 8:01 pm

CHRS

Coherus BioSciences (NASDAQ:CHRS) has received mostly bullish analyst ratings in the last quarter, with an average 12-month price target of $19.86, up 1.85% from the previous average of $19.50.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 8:00 pm